Why Farbe Firma is the Leading Injectable Manufacturer in Antigua and Barbuda
Why Farbe Firma is the Leading Injectable Manufacturer in Antigua and Barbuda
Last Updated: 23 September 2026
TL;DR: Antigua and Barbuda regulates medicines seriously, but it regulates people and premises rather than products. The Pharmacy Act and its regulations license pharmacists, pharmacies and wholesale pharmaceutical businesses, and we found no provision in force creating a national register of medicinal products. A separate statute from 1951 adds a firm-approval test for the substances in its schedule. The binding requirement for an exporter is an importer of record, not a dossier. A draft Bill would change this; it is not law.
Key Takeaways
The framework in force is the Pharmacy Act 1995, amended in 2011 and again in 2019, with the Pharmacy Regulations 2012 as amended, the 2019 instruments taking effect on 1 November 2019. On everything we were able to read, it licenses pharmacists, pharmacy technicians, pharmacies and wholesale pharmaceutical businesses. We found no product register, no marketing authorisation and no product number.
No instrument in force names a foreign regulatory authority. That means the question of whether India's CDSCO is recognised does not currently arise, and we will not say it is recognised nor that it is excluded, because you cannot be absent from a list that does not exist. A draft Pharmacy Bill would introduce a WHO Listed Authority test, but it is a draft and would commence only on an appointed day.
The importer of record is the constraint that decides entry. Under the Act as replaced in 2019, a drug may be imported only through a licensed wholesale pharmaceutical business operating from inspected premises in Antigua under the control of a registered pharmacist, at an annual licence fee of three thousand East Caribbean dollars. We found no nationality bar, so we do not assert one.
The funding picture here is unlike its neighbours and the difference matters. Antigua and Barbuda is classified by the World Bank as a high-income economy and borrows from the IBRD rather than IDA. It does not appear on the Global Fund's 2026 eligibility list or on Gavi's middle-income list. The small-island exception that reaches several Caribbean neighbours does not reach it, so the buyers are domestic and regional.
Introduction: What an Injectable Manufacturer in Antigua and Barbuda Is Actually Being Asked For
Two opposite errors are available here and both are expensive. The first is to assume a country of ninety-odd thousand people does not regulate medicines; it does, through a commenced Pharmacy Act, two commenced amendment Acts, commenced regulations and a separate commenced antibiotics statute. The second is to assume that because the regulation is real it must look like a registration regime. It does not. What is licensed is people and premises.
That distinction changes the entry plan completely. If the control point were a product dossier, the work would be regulatory writing. Because the control point is a licensed wholesale business on inspected local premises under a registered pharmacist, the work is commercial and it comes first. An exporter who spends three months assembling a dossier nobody has asked for, and has no importer of record at the end of it, has solved the wrong problem.
What Sets a World-Class Injectable Manufacturer in Antigua and Barbuda Apart
Take the layers one at a time. At the site layer we found no power asserted over a factory abroad: nothing in force provides for the inspection or licensing of an overseas manufacturing site. At the product layer, the Pharmacy Act framework creates registers of people and of premises, and we located no register of medicinal products. The importer layer is where the real requirement sits, and it is specific and checkable.
One older statute deserves separate attention. The Antibiotics and Therapeutic Substances Act, in force since 1 June 1951, requires for the substances in its schedule that goods be manufactured by a pharmaceutical firm approved by the Licensing Authority. That is a firm-by-firm approval, not a test applied to the manufacturer's home regulator, and the 1951 regulations grant it in the absolute discretion of the authority, with or without assigning any reason. We found no published list of approved firms and no criteria.
Quality Systems Behind Every Sterile Injectable Batch
Farbe Firma manufactures under WHO-GMP certification in Gujarat, India, with ISO Class 5 aseptic filling zones under continuous environmental monitoring. Where a market names no compendial standard of its own, we write specifications to the pharmacopoeia the buyer works to rather than defaulting to a house standard. Batch release rests on HPLC and GC assay and impurity work, Karl Fischer, LAL endotoxin testing, sterility, particulate matter and container-closure integrity.
Stability is designed for a hot, humid island climate rather than a temperate default, running to ICH Q1A with photostability under ICH Q1B where the molecule requires it. Long freight routes into the Eastern Caribbean consume shelf life, so remaining life at delivery is planned as a design input, and cold-chain presentations ship in validated configurations with temperature records. Dossiers are assembled in CTD and ACTD format.
Why Farbe Firma is the Trusted Injectable Manufacturer in Antigua and Barbuda for Global Buyers
Farbe Firma is a WHO-GMP certified sterile injectable manufacturer and CDMO in Gujarat, India, exporting to more than 30 countries. In a market with no product register, the documents still matter, because the licensed wholesaler, the Licensing Authority under the 1951 Act and the regional procurement service each ask for evidence and each ask for something slightly different. We supply a current WHO-GMP certificate, matching certificates of analysis and specifications written to the buyer's named standard.
The two regional mechanisms behave differently and should not be run together. The OECS Pharmaceutical Procurement Service, through which the Ministry's central procurement unit buys, asks a manufacturer to attach a certificate of GMP or ISO certification, names no issuing authority, and marks a WHO-format certificate optional. CARPHA's Caribbean Regulatory System instead works from published lists of reference authorities that do not include CDSCO. That does not close CARPHA to Indian manufacturing; it closes it to an Indian-only certificate alone, since a certificate issued for an Indian site by a reference authority would qualify.
Two things we will not overstate. Published commentary describes Antiguan imports as requiring approval from a WHO Listed Authority; that appears in a draft Pharmacy Bill published for consultation, not in law, and the source itself calls it proposed legislation. Were it enacted as drafted, scope would matter: WHO's August 2026 tables record India's CDSCO at maturity level 3 with a scope of vaccines, where Ghana, Nigeria and Tanzania are recorded with medicines.
Explore Farbe Firma: Products / Global Reach / About Us
Frequently Asked Questions (FAQ)
Does Antigua and Barbuda register or licence medicinal products?
Not on anything we found in force. The Pharmacy Act 1995 as amended and the Pharmacy Regulations 2012 as amended create registers of pharmacists, pharmacy technicians, pharmacies and wholesale pharmaceutical businesses. We located no provision establishing a register of medicinal products, no marketing authorisation and no product number. That is not the same as saying medicines are unregulated: importation, wholesale and supply are all controlled, just through the people and premises handling them.
Is India's CDSCO recognised for imports into Antigua and Barbuda?
The question does not arise under the law in force, and we will not answer it in either direction. No instrument we read names any foreign regulatory authority, so CDSCO is neither listed nor delisted; saying it is absent from a list would wrongly imply such a list exists. A draft Bill would introduce a WHO Listed Authority test for imports, but it has not been enacted and would commence only on a day appointed by the Minister.
What does the 1951 antibiotics statute require of a manufacturer?
For substances in its schedule it requires an import licence from the Licensing Authority and that the goods be manufactured by a pharmaceutical firm approved by that authority. The schedule is a short list drawn up in the 1950s covering penicillin, streptomycin, neomycin, the sulphonamide class and a few others, and many modern injectable antibiotics do not appear on it as printed. Whether a particular molecule falls inside it is a question for that authority, not one we would answer for a customer.
Can a foreign manufacturer import directly into Antigua and Barbuda?
In practice, no, though the reason is structural rather than a stated prohibition. A drug may be imported only through a licensed wholesale pharmaceutical business operating from inspected premises in Antigua under the control of a registered pharmacist, at an annual fee of three thousand East Caribbean dollars. We found no nationality restriction and do not assert one, but the premises and pharmacist conditions make a local licensee the realistic route.
Is donor funding available for medicines in Antigua and Barbuda?
No, and this is where reasoning from its neighbours goes wrong. Antigua and Barbuda is a high-income, IBRD economy on World Bank classification, not an IDA borrower, and it does not appear on the Global Fund's 2026 eligibility list or on Gavi's middle-income list. The small-island exception that keeps several Caribbean states eligible despite upper-middle-income status cannot reach a high-income country. The buyers that matter are domestic and regional.
Technically Reviewed By: Maulik Sudani (Technical Expert) | Jignasu Sudani (Technical Expert), Farbe Firma Pvt Ltd, Gujarat, India.
Farbe Firma Pvt Ltd - WHO-GMP certified sterile injectable manufacturer and CDMO, Gujarat, India. ISO Class 5 aseptic filling, CTD/ACTD dossiers, exporting to 30+ countries. director@farbefirma.orgRequest a Quote / View Products / Blog
Comments